Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010:2010:340570.
doi: 10.1155/2010/340570. Epub 2009 Oct 21.

Insulin therapy and body weight, body composition and muscular strength in patients with type 2 diabetes mellitus

H Gin  1 , V Rigalleau, C Perlemoine
Affiliations

Insulin therapy and body weight, body composition and muscular strength in patients with type 2 diabetes mellitus

H Gin et al. J Nutr Metab. 2010.

Abstract

Aims. To determine the progression of body weight (BW) and body composition (BC) in patients with type 2 diabetes mellitus (T2D) on insulin therapy and the consequences on muscle strength (MS) as a reflect of free fat mass increases. Research design and methods. We analysed BC using air displacement plethysmography and MS by hand grip dynamometry in 40 T2D before and after three (M3) and six months (M6) of insulin therapy. Results. at baseline HbA1c was 9.76 +/-1.6% and BW was stable with fat mass (FM) 28 +/- 10.7 kg; and fat free mass (FFM) 52.4 +/- 11 kg; at M6, HbA1c improved to 7.56 +/- 0.8%; insulin doses tended to increase. BW gain at M6 was + 3.2 +/- 4.2 kg and with an increase of only 25% by M3; it was composed of FM, whereas FFM was unchanged. MS did not increase on insulin therapy. Conclusions. In T2D, BW gain was composed exclusively of FM with no improvement in MS.

PubMed Disclaimer

References

    1. O’Rahilly SP, Nugent Z, Rudenski AS, et al. Beta-cell dysfunction, rather than insulin-insensitivity, is the primary defect in familial type II diabetes. The Lancet. 1986;2:360–364. - PubMed
    1. The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on body weight and composition of adults with type I diabetes in the Diabetes Control and Complications Trial. Diabetes Care. 2001;24:1711–1721. - PMC - PubMed
    1. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type II diabetes (UKPDS 33) The Lancet. 1998;352:837–853. - PubMed
    1. Charlton M, Nair KS. Protein metabolism in insulin-dependent diabetes mellitus. Journal of Nutrition. 1998;128:323S–327S. - PubMed
    1. Roubenoff R, Kehayias J. The meaning and measurment of lean body mass. Nutrition Reviews. 1991;49:163–175. - PubMed

LinkOut - more resources